Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2017
At a glance
- Drugs Cisplatin (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Gemcitabine (Primary)
- Indications Urogenital cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2017 Planned End Date changed from 1 Feb 2017 to 1 Apr 2019.
- 03 Nov 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Apr 2019.